View clinical trials related to Nasal Obstruction.
Filter by:This is Prospective Basic Science Study whose aims are as follows: 1. To determine the effect of Filtering Facepiece (FFP3M) respirators on eustachian tube function and hearing 2. To evaluate the extent to which FFP3M respirators attenuate speech in decibels The outcome measures are as follows: 1. Changes in baseline pure tone audiometry and tympanometry post intervention. 2. SNOT-22 Questionnaires before and after use of respirator 3. ETDQ7 questionnaire 4. Measurement of speech attenuation in decibels.
The purpose of this observation study is to evaluate long term safety and efficacy at 2~3 years after surgery on patients who have completed nasal septal deformity surgery using TnR Nasal Mesh.
The specific aim of this study is to determine whether pre-operative treatment with a bupivacaine nerve block can influence post-operative pain and oxycodone usage among rhinoplasty patients. Specifically, we plan to directly compare the reported pain scale, nausea, and oxycodone usage among patients who received the bupivacaine block against those of patients in the saline control condition. These assessments will be documented on day 0 (day of operation) by a nurse in the Post-Anesthesia Care Unit, while the same data points will be collected over the phone by our clinical research coordinator on post-operative days 1, 2 , 3, and 8 following discharge.
Gastroesophageal(GERD) reflux disease is a very common problem among pediatric population and has be proved to contribute in numerous otolaryngological manifestations. Trails of empirical treatment of antireflux medications is often used as a diagnostic test. However, the investigators believe GERD can cause rhinitis and nasal obstruction. Nasonex is considered as first line treatment for nasal obstruction. Hence, the proposed study aims to define the relationship between GERD and rhinitis using randomize control trial where one group of patients will receive nasonex and placebo, while the other group will receive nasonex and antireflux medications.
Demonstrate the therapeutic clinical equivalence of two mometasone nasal sprays in the relief of the signs and symptoms of perennial allergic rhinitis, in term of changes at week 8 from baseline of Total Nasal Symptom Scores (TNSS).
Sixty subjects will take part in this study. The subjects will be randomly assigned in a 1:1 ratio between the two arms of study. (Group A: Solution of Luffa Nasal Operculate 5mg/mL, Group B: saline). The subjects will use the study medication or comparative, according to their randomization, for a treatment period of 3 to 7 days. A follow-up visit will be made 15 days after initiation of treatment.